Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies

3D Breast Ultrasound In Predicting Response to Breast Cancer Therapies

The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.

To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy.

Inclusion Criteria:

• Newly diagnosed breast cancer prior to receiving breast cancer therapy.
• Diagnosis of breast cancer must be confirmed by fine needle aspiration or core biopsy.

Exclusion Criteria:

• Poorly controlled diabetes.
• Contralateral mastectomy prior to neoadjuvant chemotherapy.
• Not a surgical candidate.
• No previous axillary lymph node dissection.